Procalcitonin
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Procalcitonin (PCT) is the 116 amino acid precursor of the hormone calcitonin, produced by the C cells of the thyroid. Its synthesis is upregulated in bacterial infection and downregulated by viral infection. Consequently, with the increasing development of antibiotic resistance, interest has focused on the ability of this marker to not only diagnose infection but to tailor antibiotic treatment and help reduce the development of antibiotic resistance. The value of PCT depends on the specific clinical situation and pretest probability of disease. This article discusses the role of PCT in these different situations, namely primary care, the emergency department and the intensive care unit. The true cost effectiveness of this test remains difficult to prove as evidence for the potential impact of using PCT on slowing the development of bacterial resistance remains largely circumstantial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under normal physiological conditions, the expression and processing of CALCA mRNA into the form that encodes procalcitonin is mostly restricted to C cells of the thyroid, where the precursor protein is quickly cleaved to generate mature calcitonin.The concentration of procalcitonin in the circulation in these conditions is very low (63).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [63]
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis.
Wacker, C., Prkno, A., Brunkhorst, F. M., & Schlattmann, P. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70323-7 · Cited by 1,198
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Tang, B. M., Eslick, G. D., Craig, J. C., & McLean, A. S. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70052-x · Cited by 851
Uzzan, B., Cohen, R., Nicolas, P., Cucherat, M., & Perret, G.-Y. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000226413.54364.36 · Cited by 738
Update on Procalcitonin Measurements
Meisner, M. (2014) · Annals of Laboratory Medicine · doi:10.3343/alm.2014.34.4.263 · Cited by 395
Schuetz, P. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.318 · Cited by 386 · cited 1×
“Guidance on the interpretation of PCT results is largely based on recommendations by Schuetz et al.11 Optimal cut-offs for PCT depend on the clinical situations, which dictates the pretest probability of disease (table 2).”
MethodJensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e8791 · Cited by 356
Thompson, M., Van den Bruel, A., Verbakel, J., Lakhanpaul, M., Haj-Hassan, T., Stevens, R., Moll, H., Buntinx, F., Berger, M., Aertgeerts, B., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16150 · Cited by 324
Research works printed but not linked: 2
- Snider, 1997, Procalcitonin and its component peptides in systemic inflammation: immunochemical characterisation, J Investig Med, 45, 552
- Lloyd, 2012, Comparison of three methods for procalcitonin analysis, Med Technol SA, 26, 48
Cited by
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
Yunus, I., Fasih, A., & Wang, Y. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206527 · Cited by 118
Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis
Cong, S., Ma, T., Di, X., Tian, C., Zhao, M., & Wang, K. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06064-0 · Cited by 98
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
“In these conditions, the level of procalcitonin is decreased in the body [20].”
BackgroundGao, L., Liu, X., Zhang, D., Xu, F., Chen, Q., Ye, H., Feng, G., Shi, Q., Yang, B., & Xu, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4417 · Cited by 61
Metadata
- Authors
- Davies, J.
- Affiliations
- Wye Valley NHS Trust (GB)
- Corresponding author
- Davies, Julie
- ORCID
- Davies, Julie
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2015-06-29
- Volume
- 68
- Issue
- 9
- Pages
- 675-679
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W4253354731
- Cited by
- 135
- References
- 48
- Citations by year
- 2026: 7 · 2025: 21 · 2024: 10 · 2023: 9 · 2022: 18 · 2021: 13 · 2020: 17 · 2019: 7 · 2018: 9 · 2017: 13 · 2016: 8 · 2015: 2
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Pathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- procalcitonin, calcitonin, bacterial infection, viral infection, antibiotic resistance, antibiotic stewardship, infection diagnosis, cost-effectiveness, primary care, emergency department, intensive care unit
- MeSH terms
- Animals, Bacterial Infections, Calcitonin, Drug Resistance, Microbial, Humans, Protein Precursors, Biomarkers, Calcitonin Gene-Related Peptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Procalcitonin. https://app.cochat.ai/papers/10.1136/jclinpath-2014-202807
- The paper
- Davies, J. (2015). Procalcitonin. Journal of Clinical Pathology. https://doi.org/10.1136/jclinpath-2014-202807
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.